Correlation Between Biogen and Amgen
Can any of the company-specific risk be diversified away by investing in both Biogen and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biogen and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biogen Inc and Amgen Inc, you can compare the effects of market volatilities on Biogen and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biogen with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biogen and Amgen.
Diversification Opportunities for Biogen and Amgen
Very poor diversification
The 3 months correlation between Biogen and Amgen is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Biogen Inc and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and Biogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biogen Inc are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of Biogen i.e., Biogen and Amgen go up and down completely randomly.
Pair Corralation between Biogen and Amgen
Given the investment horizon of 90 days Biogen Inc is expected to under-perform the Amgen. In addition to that, Biogen is 1.02 times more volatile than Amgen Inc. It trades about -0.08 of its total potential returns per unit of risk. Amgen Inc is currently generating about 0.04 per unit of volatility. If you would invest 25,773 in Amgen Inc on August 24, 2024 and sell it today you would earn a total of 3,744 from holding Amgen Inc or generate 14.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biogen Inc vs. Amgen Inc
Performance |
| Timeline |
| Biogen Inc |
| Amgen Inc |
Biogen and Amgen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biogen and Amgen
The main advantage of trading using opposite Biogen and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biogen position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.| Biogen vs. Bristol Myers Squibb | Biogen vs. AbbVie Inc | Biogen vs. Merck Company | Biogen vs. Gilead Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |